We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+13.54%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$337B
AUM Growth
+$26B
Cap. Flow
-$5.42B
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.87%
Holding
3,347
New
34
Increased
1,112
Reduced
1,460
Closed
69

Top Buys

Rank Stock Value
1
FLUT icon
Flutter Entertainment
FLUT
+$489M
2
PTC icon
PTC
PTC
+$354M
3
C icon
Citigroup
C
+$286M
4
PGR icon
Progressive
PGR
+$259M
5
CRM icon
Salesforce
CRM
+$243M

Top Sells

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$574M
2
AAPL icon
Apple
AAPL
+$574M
3
TSLA icon
Tesla
TSLA
+$519M
4
PANW icon
Palo Alto Networks
PANW
+$488M
5
EOG icon
EOG Resources
EOG
+$333M

Sector Composition

Rank Sector Weight
1 Technology 29.2%
2 Financials 12.48%
3 Healthcare 11.5%
4 Consumer Discretionary 11.02%
5 Industrials 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBIO icon
3201
Orchestra BioMed
OBIO
$228M
$118K ﹤0.01%
22,296
+10,290
+86% +$69.7K
SBDS
3202
DELISTED
Solo Brands Inc
SBDS
$116K ﹤0.01%
1,342
+586
+78% +$67.3K
WKHS icon
3203
Workhorse Group
WKHS
$30.4M
$114K ﹤0.01%
162
SKYX icon
3204
SKYX Platforms
SKYX
$148M
$111K ﹤0.01%
84,826
CPSS icon
3205
Consumer Portfolio Services
CPSS
$203M
$110K ﹤0.01%
14,590
BTMD icon
3206
Biote Corp
BTMD
$69.8M
$108K ﹤0.01%
18,644
VGM icon
3207
Invesco Trust Investment Grade Municipals
VGM
$549M
$107K ﹤0.01%
10,819
BKKT icon
3208
Bakkt Inc
BKKT
$316M
$104K ﹤0.01%
9,056
TVRD
3209
Tvardi Therapeutics
TVRD
$22.8M
$104K ﹤0.01%
3,165
SST icon
3210
System1
SST
$15.6M
$98.6K ﹤0.01%
5,033
LEV
3211
DELISTED
The Lion Electric Company
LEV
$98.3K ﹤0.01%
68,951
NVCT icon
3212
Nuvectis Pharma
NVCT
$610M
$97.4K ﹤0.01%
11,883
VIGL
3213
DELISTED
Vigil Neuroscience
VIGL
$91.5K ﹤0.01%
26,840
AKTS
3214
DELISTED
Akoustis Technologies Inc
AKTS
$88.4K ﹤0.01%
149,599
LNZA icon
3215
LanzaTech
LNZA
$61.4M
$88K ﹤0.01%
284
ACRV icon
3216
Acrivon Therapeutics
ACRV
$65.1M
$84.5K ﹤0.01%
11,821
PRTH icon
3217
Priority Technology Holdings
PRTH
$550M
$82.3K ﹤0.01%
25,156
PRLD icon
3218
Prelude Therapeutics
PRLD
$362M
$79.6K ﹤0.01%
16,797
DADA
3219
DELISTED
Dada Nexus
DADA
$79.5K ﹤0.01%
38,800
DZSI
3220
DELISTED
DZS Inc. Common Stock
DZSI
$78.9K ﹤0.01%
59,788
GORV
3221
DELISTED
Lazydays
GORV
$75.7K ﹤0.01%
626
MKTW icon
3222
MarketWise
MKTW
$54.9M
$74K ﹤0.01%
2,138
OPI
3223
DELISTED
Office Properties Income Trust
OPI
$73.5K ﹤0.01%
36,023
-103,211
-74% -$355K
LNSR icon
3224
LENSAR
LNSR
$66.4M
$63.4K ﹤0.01%
17,865
ZURA icon
3225
Zura Bio
ZURA
$498M
$60.8K ﹤0.01%
23,657

Similar funds

Nuveen's Q1 2024 Portfolio in Review

As of Q1 2024, Nuveen held 3,347 positions worth $337B, up 8.4% from $311B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.1%. Nuveen opened 34 new positions and exited 69, leaving the 3,347-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q1 2024 buy was Flutter Entertainment: 2,293,926 shares worth $458M.
  • Nuveen added most to PTC in Q1 2024, an estimated $354M increase.
  • Nuveen's biggest Q1 2024 reduction was Synopsys, cutting an estimated $574M.
  • Nuveen fully exited Splunk Inc in Q1 2024, selling an estimated $159M.
  • Nuveen's ten largest holdings make up 28% of its $337B portfolio in Q1 2024.
  • Nuveen opened 34 new positions and closed 69 in Q1 2024.
  • Nuveen's portfolio value rose 8.4% quarter-over-quarter to $337B.

Based on Nuveen's 13F filing for Q1 2024, filed 13 May 2024.